Skip to content

Salubris Pharmaceuticals

Recent events

Recent events tied to this brand in public sources.

Back to profile1 entries

  1. 2022

    SalubrisBio secures $32 million in financing

    Salubris Biotherapeutics secured $32 million in financing from Shenzhen Salubris Pharmaceuticals to advance its complex biologics for several diseases.